J Vora

558 total citations
26 papers, 449 citations indexed

About

J Vora is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Neurology. According to data from OpenAlex, J Vora has authored 26 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Epidemiology and 5 papers in Neurology. Recurrent topics in J Vora's work include Diabetes Management and Research (5 papers), Neuroendocrine Tumor Research Advances (3 papers) and Chronic Disease Management Strategies (3 papers). J Vora is often cited by papers focused on Diabetes Management and Research (5 papers), Neuroendocrine Tumor Research Advances (3 papers) and Chronic Disease Management Strategies (3 papers). J Vora collaborates with scholars based in United Kingdom, United States and Australia. J Vora's co-authors include Sharon Anderson, Stephen D. Luzio, T M Hayes, Lakdasa Premawardhana, Robert E. J. Ryder, David R. Owens, Florian Jung, J R Ingelfinger, Paul Mackin and Alan Rees and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

J Vora

23 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Vora United Kingdom 9 156 104 78 77 71 26 449
Chun Chung Chow Hong Kong 13 311 2.0× 61 0.6× 48 0.6× 32 0.4× 72 1.0× 26 535
J. Mo United States 6 272 1.7× 169 1.6× 90 1.2× 86 1.1× 151 2.1× 12 654
M. Bahnsen Denmark 14 242 1.6× 52 0.5× 45 0.6× 54 0.7× 124 1.7× 25 764
Sibel Tulgar Kınık Türkiye 11 117 0.8× 21 0.2× 64 0.8× 75 1.0× 61 0.9× 40 415
Hikaru Aoki Japan 10 101 0.6× 124 1.2× 76 1.0× 24 0.3× 35 0.5× 47 435
Ole L. Myking Norway 17 220 1.4× 56 0.5× 83 1.1× 45 0.6× 21 0.3× 35 776
Alexander Shinkov Bulgaria 13 206 1.3× 38 0.4× 54 0.7× 57 0.7× 30 0.4× 44 444
Alan Sacerdote United States 10 190 1.2× 25 0.2× 74 0.9× 62 0.8× 31 0.4× 24 423
W P Stephens United Kingdom 10 122 0.8× 64 0.6× 48 0.6× 31 0.4× 40 0.6× 18 471
Robert P. Kauffman United States 15 238 1.5× 44 0.4× 81 1.0× 37 0.5× 141 2.0× 48 1.2k

Countries citing papers authored by J Vora

Since Specialization
Citations

This map shows the geographic impact of J Vora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Vora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Vora more than expected).

Fields of papers citing papers by J Vora

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Vora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Vora. The network helps show where J Vora may publish in the future.

Co-authorship network of co-authors of J Vora

This figure shows the co-authorship network connecting the top 25 collaborators of J Vora. A scholar is included among the top collaborators of J Vora based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Vora. J Vora is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zinman, Bernard, et al.. (2013). Achieving fasting plasma glucose target without nocturnal hypoglycaemia: a pooled analysis of studies in type 2 diabetes comparing insulin degludec vs insulin glargine. Diabetologia. 56. 1 indexed citations
2.
Goenka, Niru & J Vora. (2011). Commissioning specialist diabetes care. Practical Diabetes International. 28(2). 58–59. 1 indexed citations
3.
Goenka, Niru, et al.. (2011). Commissioning specialist diabetes services for adults with diabetes: summary of a Diabetes UK Task and Finish Group report. Diabetic Medicine. 28(12). 1494–1500. 14 indexed citations
4.
Goenka, Niru, et al.. (2007). Non‐alcoholic fatty liver disease: more than ‘just a bit of fatty liver’. Practical Diabetes International. 24(6). 305–308. 2 indexed citations
5.
Barnett, A H, Paul Mackin, Imran B. Chaudhry, et al.. (2007). Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia. Journal of Psychopharmacology. 21(4). 357–373. 128 indexed citations
6.
Joseph, Franklin, Benjamin Chan, Pamela Corlett, et al.. (2005). The circadian rhythm of osteoprotegerin and its association with parathyroid hormone secretion. 9. 2 indexed citations
7.
Sarker, Debashis, Jonathan J. Evans, I. Judson, et al.. (2005). CHIR-258: first-in-human phase 1 dose escalating trial of an oral, selectively targeted tyrosine kinase inhibitor in patients with solid tumors. Journal of Clinical Oncology. 23(16_suppl). 3044–3044. 2 indexed citations
8.
Moulik, Probal, T.R.K. Varma, J Vora, & Sobhan Vinjamuri. (2002). The role of somatostatin receptor scintigraphy in the management of pituitary tumours. Nuclear Medicine Communications. 23(2). 117–120. 8 indexed citations
9.
Imtiaz, Komal & J Vora. (1999). Dancing eyes-dancing feet. The Lancet. 354(9176). 390–390. 8 indexed citations
10.
Leese, GP & J Vora. (1998). New aspects of the treatment of hypertension in diabetes. Practical Diabetes International. 15(3). 82–84.
11.
Tong, C. Y. William, et al.. (1997). Severe encephalitis with rapid recovery. The Lancet. 349(9050). 470–470. 8 indexed citations
12.
Jung, Florian, et al.. (1995). Down-regulation of the intrarenal renin-angiotensin system in the aging rat.. Journal of the American Society of Nephrology. 5(8). 1573–1580. 52 indexed citations
13.
Vora, J, et al.. (1994). Altered renal vascular responses in the aging rat kidney. American Journal of Physiology-Renal Physiology. 266(6). F942–F948. 50 indexed citations
14.
Premawardhana, Lakdasa, et al.. (1992). Acromegaly and its treatment in the McCune‐Albright syndrome. Clinical Endocrinology. 36(6). 605–608. 28 indexed citations
15.
Premawardhana, Lakdasa, J Vora, & MF Scanlon. (1992). Suppurative thyroiditis with oesophageal carcinoma. Postgraduate Medical Journal. 68(801). 592–593. 17 indexed citations
16.
Luzio, Stephen D., et al.. (1991). Intravenous insulin simulates early insulin peak and reduces post-prandial hyperglycaemia/hyperinsulinaemia in type 2 (non-insulin-dependent) diabetes mellitus.. PubMed. 16(2). 63–7. 7 indexed citations
17.
Kang, Seungha, David R. Owens, J Vora, & Jens Brange. (1990). Comparison of insulin analogue B9AspB27Glu and soluble human insulin in insulin-treated diabetes. The Lancet. 335(8685). 303–306. 23 indexed citations
18.
Owens, DR, et al.. (1988). The influence of aprotinin on regional absorption of soluble human insulin.. British Journal of Clinical Pharmacology. 25(4). 453–456. 8 indexed citations
19.
Owens, David R., et al.. (1988). Soluble and Lente human insulin mixtures in normal man.. PubMed. 7(1). 35–40. 3 indexed citations
20.
Owens, DR, et al.. (1986). The metabolic response to glucagon and glucagon‐(1‐21)‐peptide in normal subjects and non insulin dependent diabetics.. British Journal of Clinical Pharmacology. 22(3). 325–329. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026